Jayme L. Dahlin

Jayme L. Dahlin serves as a preclinical medicine and high-throughput biology lead for the National Center for Advancing Translation Sciences (NCATS). Prior to joining NCATS, Dr. Dahlin completed postdoctoral training in chemical biology at the Broad Institute in the laboratories of Drs. Stuart L. Schreiber and Bridget Wagner, as well as a clinical residency in clinical pathology at Brigham & Women’s Hospital/Harvard Medical School. He serves on the editorial board of the NIH Assay Guidance Manual and the Scientific Expert Review Panel of the Chemical Probes Portal. His research interests include chemical mechanisms of biological assay interference, high-throughput screening, and chemical biology.

More from Jayme

Join the Drug Hunter Mailing List

to get free content and resources weekly. Trusted by >8,000 drug hunters worldwide. Unsubscribe anytime.